Figure 1.
Trial design. FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; IDeg, insulin degludec; Lira, liraglutide; Met, metformin; SMPG, self‐measured plasma glucose; V, visit.
Trial design. FPG, fasting plasma glucose; HbA1c, glycated haemoglobin; IDeg, insulin degludec; Lira, liraglutide; Met, metformin; SMPG, self‐measured plasma glucose; V, visit.